U2AF1 and myelodysplastic syndrome: However, U2AF1 mutations/variants show a significant correlation with worse OS and progression-free survival compared to U2AF1 unmutated cases in multiple MDS patient cohorts [23,27,29,30,32,33,34,35,36,37,38,39,51,52].